Onco-Innovations Limited (W1H)
Market Closed
14 Aug, 20:00
XDUS XDUS Primary €
0. 33
-0.03
-8.9655%
€
- Market Cap
- P/E Ratio
- Div Yield
100 Volume
- Eps
€ 0.36
Previous Close Want to track W1H and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Onco-Innovations Limited (W1H) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -2.7
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) -
Price/Book (mrq) 94.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 57.55M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 520
Average volume (90 days) 587
Price summary
52-Week low 0.33
52-Week high 1.25
Beta -
50-Day moving average 0.51
200-Day moving average 0.79
Financials
Fiscal year
Fiscal year ends 30 Apr 2025
Most recent quarter (mrq) 31 Jan 2026
Profitability
Profit margin -
Operating margin -71.92%
Operational effectiveness
Return on assets -3.84%
Return on equity -4.71%
Income Statement
Revenue (ttm) 65.29K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -8.49M
Diluted EPS (ttm) -0.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 514.04K
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.87%
Book value per share (mrq) 0.01
Cash Flow
Cash flow statement -6.65M
Levered free cash flow (LFCF) -8.49M
